Miss your deceased dog? Pet cloning dips below $100,000

dpo jferhyjpg

For $150,000, you could buy a ticket for a suborbital tourist space flight, pay off your student loans, possibly even buy a house, or immunize thousands of children in Somalia against polio, but how about cloning your pet? That’s what Edgar and Nina Otto did back in 2009. After keeping the DNA of their deceased Labrador, Sir Lancelot, in frozen storage for a year while the technology developed, the Florida couple traveled to Sooam Biotech in South Korea, where the DNA was injected into a host egg to create an embryo genetically identical to Lancelot.

Dubbed Lancelot Encore, the puppy became the first commercially cloned dog, but not the first commercially cloned pet; that honor goes to a cat, Little Nicky, who was created for a mere $50,000.

More recently, others have followed in the Otto’s footsteps, and the price of the dog cloning procedure at Sooam has now dipped below $100,000. And there’s competition from another South Korean company, RNL Bio, leading to what Time Magazine has dubbed “South Korea’s Pet Clone Wars“.

Harsh criticism

Scanning the reader comments on various pet cloning articles in popular media, most people appear to be negative. Some are more polite, others more harsh, but many make the point that, of course, the clone is a completely new animal and not a replica of the deceased pet. In the words of cloning expert, Robert Lanza, chief scientific officer at Advanced Cell Technology,

Anyone who thinks they might be able to get Spot or Fluffy back is mistaken. Cloned animals have distinct personalities, just like identical twins.

Beyond criticism of the clients who get their pets clone, it should be no surprise that the budding pet cloning industry is getting harsh criticism from animal rights groups, along with pretty much anyone concerned with social justice. People are putting so much money and effort into reproducing essentially a different animal that merely resembles somebody’s deceased pet when the money could be used to help thousands of homeless dogs and cats, or for that matter to help human society, but this is not the only ethical issue.

While Sooam has cloned hundreds of animals and provided many families what they’ve requested, including Lancelot Encore who has since grown up to father many of his own puppies, many clones do not survive on account of medical abnormalities. According to Lanza,

Anyone who wants to have their pet cloned should ask themselves if they are willing to have one or two defective copies of “Fluffy” or “Spot” put down in order to get their pet back.

Also, even when several healthy clones are produced in one litter, the client may want just one of them.

Beyond pet duplication

Sooam is now partnering with a Chinese company, BoyaLife, to expand into China where the goal is not merely to provide private individuals with duplicates of their deceased pets for emotional reasons. Instead, the idea is to clone very special sniffer dogs. Employed for police work and bomb sniffing, or for sniffing out cancer and other medical conditions, especially talented sniffer are not so easily bred. Moreover, BoyaLife is not thinking only about dogs and cats.

“Dogs are the entry point…We want to do all this not just for profit, but also for history.” says Dr. Xu Xiao-chun, BoyaLife’s CEO who emphasizes that the company will be expanding to cow cloning to increase beef production. That sounds practical, but along with that he also is considering something a little more exotic side, but also perfectly appropriate for China: cloning a giant panda.

David Warmflash is an astrobiologist, physician, and science writer. Follow @CosmicEvolution to read what he is saying on Twitter.

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-06-17-at-12.31.01-PM
Viewpoint: The dangerous influence of ‘woke’ post-modernism in science
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
marijuana-pot-in-hand-nveri-st-xpm-t-abq-fkifeos-s-rws-cmpx-
Facts & Fallacies podcast: Legalized weed drives drug addiction, psychosis?
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
Sampling_a_strawberry_32206461974
Viewpoint: Which is worse: Trace PFAS ‘forever chemicals’ on strawberries or the fear that scares people away from eating them?
ChatGPT-Image-Mar-4-2026-09_39_03-AM
Transgender female athletes and Title IX: Separating ‘policy’ from ‘legality’
photodune farming tractor s
Viewpoint: Glyphosate may be hazardous, but it is not dangerous as used by farmers. Critics of the Supreme Court’s Roundup ruling garble hazard with risk
ChatGPT-Image-Jun-25-2026-01_14_50-PM
Viewpoint: Disinformation grift: The wellness industry is a lucrative and mostly worthless marketplace of ‘balms, brews, and baloney’
ChatGPT-Image-Jun-30-2026-11_55_58-AM
Viewpoint—Junk science: How predatory mass tort lawyers twist facts, scare the public about phantom chemical risks, and cash in on billion-dollar settlements
NYPICHPDPICT000011561063
Viewpoint: From magnetizing your head to taking useless supplements, the wellness craze has morphed into an obsession of the affluent
covid-vaccine
Blocked by Kennedy’s CDC, validated by peer-reviewed scientists: Suppressed COVID vaccine study published in JAMA finds 50% risk cut
ChatGPT-Image-Jun-19-2026-04_11_20-PM
Daubert for Dummies—Scientific Reliability in U.S. Courts: Daubert, Rule 702, and Made-for-Litigation Evidence
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.